✨ Free AI Report
Elixinol Global Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Elixinol Global Limited
Company Research

Elixinol Global Limited: Business Overview, Financials & Competitive Analysis

Elixinol Global Limited scores 3/10 on the AskCyborg Cyborg Score (Challenged). Micropublisher with challenged profitability operating in nascent hemp/CBD market, dependent on regulatory developments and B2B/DTC execution. As of June 2026, market cap stands at A$2.9 million. The company shows negative TTM earnings per share of -0.022. The company faces significant valuation pressure and profitability challenges despite multi-brand portfolio and.

What is Elixinol Global Limited's industry? Elixinol Global Limited (elixinol.com) operates in Cannabis. AskCyborg classifies Elixinol Global Limited under Cannabis in its company registry.

Elixinol Global manufactures and distributes hemp-derived cannabidiol (CBD) products and plant-derived food, skincare, and nutraceutical products. The company distributes through grocery, wholesale, and e-commerce cha...

3/ 10Challenged

Cyborg Score thesis

Micropublisher with challenged profitability operating in nascent hemp/CBD market, dependent on regulatory developments and...

Read the full analyst-debate transcript →
Industry Cannabis
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Elixinol Global Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Elixinol Global Limited

AskCyborg analysts argue the bull and bear cases for Elixinol Global Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Elixinol Global Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Elixinol Global Limited Overview

Pro stress-test →

Elixinol Global manufactures and distributes hemp-derived cannabidiol (CBD) products and plant-derived food, skincare, and nutraceutical products. The company distributes through grocery, wholesale, and e-commerce channels for white label customers, as well as food, beverage, and beauty manufacturers. It operates as a publicly traded Australian wellness company with global reach.

Strategic Profile

Pro stress-test →

In Australia, Elixinol operates a vertically integrated business producing and distributing products across four verticals: human nutrition, human wellness, pet wellness and superfood ingredients. Products are sold under brands including Hemp Foods Australia, The Healthy Chef, Mt Elephant, and Soul Seed. The company maintains dual geographic focus with Australian vertical integration and Americas-based branded nutraceutical operations.

Competitive Landscape

Pro stress-test →

Elixinol competes in the hemp-derived wellness and CBD product space against larger established nutraceutical, supplement, and consumer packaged goods companies. The market includes both pure-play CBD companies and diversified consumer health brands. Limited direct public comparables in the Australian cannabis/hemp sector.

Industry Context

Elixinol Global Limited operates in Cannabis.

Key facts

Founded: 2017 · Headquarters: Newtown, Australia · Market cap: A$2.9M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Elixinol Global Limited.

  • Stock price trading at A$0.007 (as of June 2026).
  • Operates vertically integrated Australian business with four product verticals and multiple consumer brands across grocery, wholesale and e-commerce.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • June 2026Market cap at A$2.9M with stock trading at A$0.007
  • February 2026Director shareholding updates reported
  • +1 moreTrack every material event for Elixinol Global Limited as it happens. Explore monitoring →
Get alerted when Elixinol Global Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Cann Group CBD ProductsAustralian cannabis producer with CBD focus→Hemp & CBD SupplementsHemp-derived CBD wellness products (US-based)→Nutritional Supplements & Plant-Based NutraceuticalsEstablished Australian nutritional supplement leader→

Compare Elixinol Global Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Elixinol Global Limited operates in Cannabis. See how the rest of the sector scores on the Cyborg framework.

Browse Cannabis research →
NEW · MCP server

Ask your AI assistant about Elixinol Global Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Elixinol Global Limited and its top competitor on Cyborg Score”
“What did Elixinol Global Limited do this quarter?”
“Is Elixinol Global Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Elixinol Global Limited do?+
Elixinol Global manufactures and distributes hemp-derived cannabidiol (CBD) products and plant-derived food, skincare, and nutraceutical products. The company distributes through grocery, wholesale, and e-commerce cha...
What is Elixinol Global Limited's Cyborg Score?+
Elixinol Global Limited has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Elixinol Global Limited's main competitors?+
Named competitors include Cann Group CBD Products, Hemp & CBD Supplements, Nutritional Supplements & Plant-Based Nutraceuticals. The full competitive landscape is in the AskCyborg report.
How can I get the full Elixinol Global Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Elixinol Global Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Elixinol Global Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Cannabis research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Cronos Group Inc.6Ayr Wellness